ArticleNature and science of sleep2025
Development of the Sleeping Pills Receptivity and Involuntariness Scale-6 (SPRIS-6) to Assess Acceptance of Hypnotics Use.
Article in Nature and science of sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Assessing an individual's acceptance of sleep medications is valuable for clinicians, as it may be the starting point for discussing the treatment of insomnia, whether pharmacologically or nonpharmacologically. This study developed a rating scale for measuring psychological receptivity to hypnotics and validated it in a general population. Methods: We conducted an anonymous survey in a general Korean population. First, we developed a rating scale for psychological receptivity to hypnotic use using exploratory factor analysis (EFA) in Sample I (N = 300), followed by confirmatory factor analysis (CFA) in Sample II (N = 300). Convergent validity was assessed using the Insomnia Severity Index (ISI), Glasgow Sleep Effort Scale (GSES), Adaptive Cognition and Behaviors about Sleep-6 (ACBS-6), and Acceptance and Action Questionnaire-II (AAQ-II). Results: From the EFA, six survey items were selected from the collected items. The CFA among Sample II showed a good fit for the two-factor model (Factor 1: Involuntary nature of insomnia; Factor 2: Acceptance of sleep medication use) of our Sleeping Pills Receptivity and Involuntariness Scale-6 (SPRIS-6) (comparative fit index = 0.99, Tucker-Lewis index = 0.99, root-mean-square-error of approximation = 0.02, and standardized root-mean-square residual = 0.02). According to the multi-group CFA, the two-factor structure of the SPRIS-6 measures psychological receptivity to sleep medications in the same way, regardless of whether or not participants reported insomnia. Using McDonald's coefficient of 0.80, the two-factor structure of the SPRIS-6 demonstrated good internal consistency. Linear regression analysis showed that the ISI score was positively influenced by the SPRIS-6 (β = 0.16, p = 0.002), GSES (β = 0.49, p = 0.001), and AAQ-II (β = 0.18, p = 0.001), whereas it was inversely influenced by the ACBS-6 (β = -0.10, p = 0.037). Conclusion: The SPRIS-6 is a reliable and valid rating scale that measures psychological receptivity to sleep medication use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.